US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

iHuman

1.97

-0.1941-8.99%

Post-market: 1.970.00000.00%17:48 EDT

Volume:134.26K

Turnover:273.53K

Market Cap:102.26M

PE:7.97

High:2.15

Open:2.15

Low:1.94

Close:2.16

Loading ...

Overview Company News Filings

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Do Its Financials Have Any Role To Play In Driving iHuman Inc.'s (NYSE:IH) Stock Up Recently?

Simply Wall St.

Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results

Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline

Ihuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

THOMSON REUTERS

Ihuman Q4 Gross Profit RMB 156.4 Million

THOMSON REUTERS

Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

CNH Industrial says precision technology helping farmers tackle water scarcity

Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

The recent 11% gain must have brightened Top Key Executive Yufeng Chi's week, iHuman Inc.'s (NYSE:IH) most bullish insider

Simply Wall St.

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","market":"US","secType":"STK","nameCN":"iHuman","latestPrice":1.9659,"timestamp":1743796800000,"preClose":2.16,"halted":0,"volume":134259,"hourTrading":{"tag":"盘后","latestPrice":1.9659,"preClose":1.9659,"latestTime":"17:48 EDT","volume":5,"amount":9.5,"timestamp":1743803281921},"delay":0,"floatShares":15216840,"shares":52016841,"eps":0.246606,"marketStatus":"Market Closed","change":-0.1941,"latestTime":"04-04 16:00:00 EDT","open":2.15,"high":2.15,"low":1.94,"amount":273534.60315,"amplitude":0.097222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.246606,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1602216000000,"exchange":"NYSE","adjPreClose":2.16,"preHourTrading":{"tag":"盘前","latestPrice":2.139,"preClose":2.16,"latestTime":"09:05 EDT","volume":9700,"amount":20756.10268,"timestamp":1743771926181},"postHourTrading":{"tag":"盘后","latestPrice":1.9659,"preClose":1.9659,"latestTime":"17:48 EDT","volume":5,"amount":9.5,"timestamp":1743803281921},"volumeRatio":3.4965311841068876},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","floatShares":15216840,"roa":"3.13%","roe":"10.28%","lyrEps":0.257765,"volumeRatio":3.4965311841068876,"shares":52016841,"dividePrice":0,"high":2.15,"amplitude":0.097222,"preClose":2.16,"low":1.94,"week52Low":1.47,"pbRate":"0.78","psRate":"0.81","week52High":3.18,"institutionHeld":0,"latestPrice":1.9659,"eps":0.246606,"divideRate":0,"volume":134259,"delay":0,"ttmEps":0.246606,"open":2.15,"prevYearClose":1.69,"prevWeekClose":2.33,"prevMonthClose":2.12,"prevQuarterClose":2.12,"fiveDayClose":2.33,"twentyDayClose":2.08,"sixtyDayClose":1.73},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524473204","title":"Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2524473204","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524473204?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:17","pubTimestamp":1743772637,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Harmony Biosciences Holdings, Inc.  on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. 's share was trading at $30.97 as of April 3rd. HRMY’s trailing and forward P/E were 12.34 and 8.72 respectively according to Yahoo Finance.Looking ahead, the upside potential is substantial. Management projects WAKIX sales of $820–$860 million in 2025 and over $1 billion by 2027. More significantly, six Phase 3 programs are expected to be in development by the end of 2025, and the company aims to launch a new product every year through 2030. This could drive total sales to over $3 billion by 2028. Of particular note is ZYN-002, targeting Fragile X Syndrome, which has no current treatment but affects over 80,000 patients. Fast-tracked by the FDA, ZYN-002 could launch as early as 2026 and—with full ownership—wou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-holdings-inc-hrmy-131717960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LU0820562030.AUD","LU2756315664.SGD","LU0868494708.USD","LU1551013425.SGD","BK4581","BK4563","LU1914381329.SGD","HD","IH","LU1093756325.SGD","BK4567","LU1989772840.SGD","BK4533","LU0868494617.USD","BK4534","LU0234572021.USD","LU2756315318.SGD","LU0354030511.USD","IE00B1XK9C88.USD","LU0820561818.USD","BK4504","LU0823411888.USD","LU0943347566.SGD","LU0079474960.USD","LU1069344957.HKD","LU1162221912.USD","LU1551013342.USD","LU0823434740.USD","IE00BWXC8680.SGD","IE00BZ1G4Q59.USD","LU1496350502.SGD","HRMY","LU1929549753.HKD","SG9999001440.SGD","LU0354030438.USD","LU1035775433.USD","LU0942090050.USD","LU1674673691.USD","LU1778281490.HKD","LU1989772923.USD","LU0689472784.USD","LU0823434583.USD","IE00BSNM7G36.USD","LU0320765646.SGD","BK4007","IE00BKVL7J92.USD","BK4083","BK4510","BK4550"],"gpt_icon":0},{"id":"2524253635","title":"Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253635","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253635?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:30","pubTimestamp":1743679800,"startTime":"0","endTime":"0","summary":"Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April  03, 2025  (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-sta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3055022/0/en/Incannex-Healthcare-Completes-Phase-2-Enrollment-in-RePOSA-Phase-2-3-Trial-of-IHL-42X-an-Oral-Once-Daily-Treatment-for-Obstructive-Sleep-Apnea-OSA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","BK4181","AHI","BK4218","BK4563","PK","BK4085","BK4510","BK4097","BK4167","IH","BK4137"],"gpt_icon":0},{"id":"2522041993","title":"Do Its Financials Have Any Role To Play In Driving iHuman Inc.'s (NYSE:IH) Stock Up Recently?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522041993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522041993?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:50","pubTimestamp":1743083434,"startTime":"0","endTime":"0","summary":"Most readers would already be aware that iHuman's  stock increased significantly by 28% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. Particularly, we will be paying attention to iHuman's  ROE today.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company's success at turning shareholder investments into profits.Return on equity can be calculated by using the formula:. Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for iHuman is:. The 'return' is the yearly profit. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.10.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/financials-role-play-driving-ihuman-135034326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4510","NYSE","BK4085","IH"],"gpt_icon":0},{"id":"1140767178","title":"Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1140767178","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140767178?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:59","pubTimestamp":1742918347,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc. $$ plunged 5.79% in Tuesday's trading session after the Chinese educational technology company reported weaker-than-expected financial results for the fourth quarter and full year of 2024.The Beijing-based firm, which provides tech-powered intellectual development products, saw its revenue decline 7.1% year-over-year to RMB232.7 million  in the fourth quarter. Net income for the quarter fell to RMB26.5 million , compared to RMB33.3 million in the same period last year. The ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"1113014243","title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1113014243","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113014243?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:58","pubTimestamp":1742918333,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc.  plummeted 5.79% in intraday trading on Tuesday after the company reported declines in revenue and profit for the fourth quarter of 2024. The Chinese provider of tech-powered intellectual development products saw its financial performance impacted by demographic trends and cautious consumer spending.iHuman's fourth-quarter revenue fell 7.1% year-over-year to RMB232.7 million , down from RMB250.4 million in the same period last year. The company attributed this decline to Ch","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2522912360","title":"Ihuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522912360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522912360?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA6BQH7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4085","BK4563","BK4510","IH"],"gpt_icon":0},{"id":"2522904091","title":"Ihuman Q4 Gross Profit RMB 156.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522904091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522904091?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLX878E6F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4510","BK4085","BK4563","IH"],"gpt_icon":0},{"id":"2522609170","title":"Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522609170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522609170?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889780,"startTime":"0","endTime":"0","summary":"BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc.  , a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.-- Revenues were RMB232.7 million , compared with RMB250.4. RMB178.2 million in the same period last year.RMB21.9 million in the same period last year.-- Net income was RMB26.5 million , compared with RMB33.3. -- Average total MAUs[1] for the fourth quarter were 25.78 million, compared. At the heart of our success is our long-standing dedication to technological innovation, particularly in artificial intelligence. Since establishing our AI Lab in 2018, we have consistently invested in cutting-edge advancements and seamlessly integrated them into our product offerings. By embracing transformative technologies such as AI-generated content , we became one of the first companies in China to develop and launch a proprietary large language model , a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","IH","BK4563","BK4085"],"gpt_icon":0},{"id":"2521538747","title":"CNH Industrial says precision technology helping farmers tackle water scarcity","url":"https://stock-news.laohu8.com/highlight/detail?id=2521538747","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521538747?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:45","pubTimestamp":1742816742,"startTime":"0","endTime":"0","summary":"The company said, “Following World Water Day on March 22, CNH brands – Case IH and New Holland – continue to lead the way in breaking new ground in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cnh-industrial-says-precision-technology-helping-farmers-tackle-water-scarcity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cnh-industrial-says-precision-technology-helping-farmers-tackle-water-scarcity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","LU0630314457.HKD","LU1803068623.USD","LU0130518102.USD","BK4152","LU1863844749.USD","CNH","IH","BK4510","LU0130103400.USD","LU0345781412.USD","LU0648000940.SGD","LU0889565080.SGD","LU0345780950.USD","LU1863844665.USD","BK4085","BK4563","LU0477156797.USD"],"gpt_icon":0},{"id":"2521745072","title":"Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745072?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024. -- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise with key data readouts expected in 2025. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  well underway and on track with data expected across all. three indications in 2025 with first-in-class potential in NT2 and. Dr. Saha concluded, \"In addition to the transformational potential of ORX750 for individuals living with sleep-wake disorders, we see tremendous opportunity with our follow-up OX2R agonists that are being advanced for the treatment of EDS, impaired attention, cognitive deficits and fatigue in neurological, neurodegenerative and neuropsychiatric disorders. ORX142 is prog","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSL","BK4563","BK4022","PK","BK4085","BK4585","AAN","BK4535","IH","BK4232","NSS","BK4181","BK4139","BK4597","BK4178","ESS","R","BK4539","BK4218","BK4588","BK4215","BK4510","CNTA"],"gpt_icon":0},{"id":"2520199470","title":"HRMY Down 10.8% in Six Months: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199470","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199470?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:14","pubTimestamp":1742400840,"startTime":"0","endTime":"0","summary":"Shares of Harmony Biosciences HRMY have lost 10.8% in the past six months compared with the industry’s decline of 9.7%. The stock has also underperformed the S&P 500 index during this timeframe.The stock was hit last month after the company announced that it received a Refusal to File  letter from the FDA for pitolisant for the treatment of excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Nonetheless, the fourth-quarter results reported on Feb. 25 were better-than-expected and shares recovered a bit.Let’s dig deeper and understand the company’s strengths and weaknesses in detail to understand how to play the stock in such a scenario.HRMY’s Efforts to Expand Wakix’s Label Suffer Setback. The company was looking to expand the drug’s label for EDS in adult patients with IH. The supplemental new drug application  for pitolisant in IH was submitted in the fourth quarter based on data from the INTUNE study and additional sources.The company targets to initiate a p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-down-10-8-six-161400902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HRMY","IH","BK4085","JAZZ","LU0320765992.SGD","BK4533","BK4563","BK4585","LU0823416689.USD","FXS","LU0109394709.USD","IE00BN0W2V16.EUR","BK4007","AXSM","BK4532","IE00BN0W2T93.GBP","BK4505","BK4510","LU0889565916.HKD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2518710297","title":"Zevra Reports Full Year 2024 and Fourth Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518710297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518710297?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:05","pubTimestamp":1741723500,"startTime":"0","endTime":"0","summary":"FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million duringfourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million  Company to host confer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040981/16626/en/Zevra-Reports-Full-Year-2024-and-Fourth-Quarter-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4202","BK4085","IH","AS","CPS","BSA","BK4563","BK4124"],"gpt_icon":0},{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKT","SMC","RKT","BKKT","BK4607","HUT","CME","MCHP","NOVA","LU0048584097.USD","DASH","PRMB","LU0289739699.SGD","REGN","ADM","W","DXCM","STSS","IH","MLYS","TKO","SXTC","ABNB","TSYW.SI","BK4599","CBRL","NEM","LU0354030511.USD","CKPT","RDFN","TRVI","WLFC","LU0889565833.HKD","PTGX","EXE","MNDR","WSM","NOW","ENPH","BECN","FENC","FBIO"],"gpt_icon":1},{"id":"2517191113","title":"Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191113?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:14","pubTimestamp":1741295640,"startTime":"0","endTime":"0","summary":"BOSTON and LONDON, March 06, 2025  -- Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that data from the Phase 1 clinical trial of ORX750, an investigational novel highly potent and selective OX2R agonist being progressed for the treatment of narcolepsy type 1 , narcolepsy type 2  and idiopathic hypersomnia , will be presented in a poster sessionat the American Academy of Neurology  2025 Annual Meeting being held April 5-9, 2025, in San Diego, CA. ORX750 is being evaluated in an ongoing Phase 2a clinical trial  in participants with NT1, NT2 and IH.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/centessa-pharmaceuticals-announces-poster-presentation-211400184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4510","BK4178","BK4539","IH","BK4117","BK4139","BK4535","BK4085","BK4107","AAN","CNTA","AFG"],"gpt_icon":0},{"id":"1159599743","title":"Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=1159599743","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159599743?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:37","pubTimestamp":1741012673,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc. , a biopharmaceutical company focused on transforming medicines, skyrocketed 6.54% in pre-market trading on Monday. The surge came after the company reported impressive financial results for the fourth quarter and full year 2024, driven by strong sales of its flagship product Lumryz, and reaffirmed its 2025 guidance.The key highlights that fueled the stock rally include a 158% year-over-year increase in Lumryz sales to $50.4 million in Q4 2024, taking the full-year total to","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2516217687","title":"Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2516217687","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516217687?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"-- LUMRYZ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line with preliminary results published January 8 -- Reiterat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035460/0/en/Avadel-Pharmaceuticals-Reiterates-2025-Guidance-as-it-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4563","IH","BK4085","BK4135","CNS"],"gpt_icon":0},{"id":"2514341644","title":"The recent 11% gain must have brightened Top Key Executive Yufeng Chi's week, iHuman Inc.'s (NYSE:IH) most bullish insider","url":"https://stock-news.laohu8.com/highlight/detail?id=2514341644","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514341644?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:03","pubTimestamp":1740737024,"startTime":"0","endTime":"0","summary":"Insiders appear to have a vested interest in iHuman's growth, as seen by their sizeable ownership. 55% of the company is held by a single shareholder . Ownership research, combined with  past performance data  can help provide a good understanding of opportunities in a stock. To get a sense of who is truly in control of iHuman Inc. , it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 70% to be precise, is individual insiders. That is, the group stands to benefit the most if the stock rises .As a result, insiders scored the highest last week as the company hit US$107m market cap following a 11% gain in the stock.Let's delve deeper into each type of owner of iHuman, beginning with the chart below.The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recent-11-gain-must-brightened-100344847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4510","NYSE","BK4563","BK4085","IH"],"gpt_icon":0},{"id":"2514904483","title":"Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904483","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904483?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:05","pubTimestamp":1740517500,"startTime":"0","endTime":"0","summary":"– Record total revenues of $4.1 billion in 2024 and $1.1 billion in 4Q24 –– Xywav and Epidiolex revenues grew 16% and 15% year-over-year, respectively, in 2024 –– Oncology revenues grew 9% year-over-yearin 2024, surpassed $1.1 billion –– Ziihera approved in 2L HER2+  BTC; first sales achieved in December 2024 –– 2025 guidance reflects continued top- and bottom-line growth –。DUBLIN, Feb. 25, 2025 /PRNewswire/ --Jazz Pharmaceuticals plc  today announced financial results for the full year and fourth quarter of 2024 and provided guidance for 2025.Mr. Cozadd continued, \"The strength of our 2024 results reinforces our confidence that Jazz is well-positioned to deliver top- and bottom-line growth in 2025 and drive long-term shareholder value. Our focus remains on disciplined capital allocation, which we expect to drive growth of our diversified commercial portfolio, continue advancement of our pipeline and provide flexibility to remain active in corporate development.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-full-fourth-210500947.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-full-fourth-210500947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2355687059.USD","IE00BN0W2T93.GBP","BK4563","LU1880398471.USD","IE00BMG7P587.USD","LU0109394709.USD","BTC","BK4085","IE00B29SXK94.USD","BK4585","BK4107","LU1699723380.USD","LU1571399168.USD","BK4532","IE00BZ18W340.USD","LU2449327464.USD","IE00BMQBXF63.USD","LU1803068623.USD","LU1880398554.USD","LU1883839398.USD","IE00BN0W2V16.EUR","AG","IE00BZ18W456.USD","IH","IE00BMG7P819.SGD","ALL","LU0889565916.HKD","LU0320765992.SGD","IE00BMG7P926.USD","IE00BN0W2W23.USD","IE00BMG7P694.USD","JAZZ","ES","IE00B29SXL02.USD","BK4533","LU0985320562.USD","BK4007","BK4210","LU2637428348.USD","BK4588","BK4081","BK4510"],"gpt_icon":0},{"id":"2513266587","title":"Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2513266587","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513266587?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"DUBLIN, Feb.  24, 2025  (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that Kevin Springman ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031098/0/en/Avadel-Pharmaceuticals-Appoints-Kevin-Springman-as-Vice-President-of-Sales.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","CNS","BK4085","BK4135","BK4563","IH"],"gpt_icon":0},{"id":"2512439602","title":"Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2512439602","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512439602?lang=en_us&edition=fundamental","pubTime":"2025-02-20 03:24","pubTimestamp":1739993040,"startTime":"0","endTime":"0","summary":"On Wednesday, Harmony Biosciences Holdings, Inc.  received a Refusal to File  letter from the U.S. Food and Drug Administration  for pitolisant for excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Harmony’s 2025 net revenue guidance of $820 million-$860 million remains unchanged.Also Read: Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says. Although the primary outcome for excessive daytime sleepiness  between pitolisant and placebo did not reach statistical significance in the randomized withdrawal phase of the Phase 3 INTUNE Study, the data from the open-label phase showed that patients experienced improvements on the Epworth Sleepiness Scale that were five times greater than what is recognized as clinically meaningful.Pitolisant is marketed as Wakixin the U.S. for EDS or cataplexy in adult patients with narcolepsy and for EDS in pediatric patients 6 years of age and older with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-stock-falls-fda-192400581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4510","IH","BK4563","HRMY","BK4085"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IH\",params:#limit:5,,,undefined,":[{"date":"2025-04-17","symbol":"IH","amount":0.1,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-17","defaultRemindTime":1744896600000,"name":"洪恩","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-17","currency":"USD","dateTimestamp":1744862400000,"payDate":"2025-05-15"},{"market":"US","date":"2025-03-25","symbol":"IH","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-12-26","symbol":"IH","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1735189200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-09-27","symbol":"IH","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2024-06-28","symbol":"IH","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1719547200000,"reportTimeType":"pre","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IH\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-27","recordDate":"2024-03-28","paymentDate":"2024-05-15","value":0.1,"currency":"USD"},{"executeDate":"2025-04-17","recordDate":"2025-04-17","paymentDate":"2025-05-15","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IH","date":"2025-04-04","current":8.29809,"percent":0.753176,"low":-133.902359,"twenty":-46.382185,"median":4.29859,"eighty":10.589398,"high":5530.113888,"avg":174.967851,"sd":791.291526,"marketCap":112356376},"quantilePoints":[{"date":"2020-10-09","current":3015.153489,"twenty":2293.787118,"median":2293.827654,"eighty":2726.623155,"marketCap":836391616},{"date":"2020-10-16","current":4671.672124,"twenty":2582.357988,"median":4320.874306,"eighty":4827.609099,"marketCap":1295361515},{"date":"2020-10-23","current":3576.429918,"twenty":3054.346825,"median":3950.507078,"eighty":4590.121793,"marketCap":993215044},{"date":"2020-10-30","current":3382.234713,"twenty":3220.775982,"median":3568.61436,"eighty":4432.812866,"marketCap":938849588},{"date":"2020-11-06","current":4034.939846,"twenty":3394.42959,"median":3740.899882,"eighty":4332.766989,"marketCap":1133310639},{"date":"2020-11-13","current":4488.973537,"twenty":3422.358528,"median":3821.187811,"eighty":4445.304782,"marketCap":1261905850},{"date":"2020-11-20","current":4767.084272,"twenty":3466.034133,"median":3950.507078,"eighty":4477.549968,"marketCap":1348681480},{"date":"2020-11-27","current":5353.033215,"twenty":3519.796499,"median":4037.558213,"eighty":4638.086879,"marketCap":1511255101},{"date":"2020-12-04","current":804.947539,"twenty":3417.540217,"median":4036.249029,"eighty":4748.001842,"marketCap":1214336077},{"date":"2020-12-11","current":790.928981,"twenty":2438.092821,"median":3871.756867,"eighty":4638.086879,"marketCap":1190289818},{"date":"2020-12-18","current":773.47919,"twenty":839.797655,"median":3809.879703,"eighty":4500.791427,"marketCap":1165720814},{"date":"2020-12-24","current":703.755238,"twenty":804.795355,"median":3658.6649,"eighty":4488.973537,"marketCap":1061694607},{"date":"2020-12-31","current":627.687586,"twenty":782.034363,"median":3560.160364,"eighty":4485.036639,"marketCap":947213505},{"date":"2021-01-08","current":693.040329,"twenty":735.871662,"median":3436.813461,"eighty":4471.047521,"marketCap":1054898925},{"date":"2021-01-15","current":631.925226,"twenty":705.894649,"median":3247.685771,"eighty":4422.813267,"marketCap":960804868},{"date":"2021-01-22","current":785.483217,"twenty":699.469274,"median":2654.490571,"eighty":4392.829635,"marketCap":1193949031},{"date":"2021-01-29","current":629.066628,"twenty":676.404566,"median":880.984684,"eighty":4370.542391,"marketCap":963941337},{"date":"2021-02-05","current":656.411833,"twenty":657.588495,"median":826.141001,"eighty":4316.280848,"marketCap":1000010725},{"date":"2021-02-12","current":731.808279,"twenty":655.410123,"median":804.795355,"eighty":4271.81883,"marketCap":1116582807},{"date":"2021-02-19","current":677.913997,"twenty":656.651329,"median":790.928981,"eighty":4262.599202,"marketCap":1034511880},{"date":"2021-02-26","current":635.403102,"twenty":651.117511,"median":778.826173,"eighty":4171.869822,"marketCap":967077806},{"date":"2021-03-05","current":520.076355,"twenty":646.138503,"median":752.847189,"eighty":4036.510866,"marketCap":788821842},{"date":"2021-03-12","current":549.771961,"twenty":636.290266,"median":736.659373,"eighty":4001.166739,"marketCap":832209657},{"date":"2021-03-19","current":530.498446,"twenty":628.593395,"median":733.320641,"eighty":3919.006994,"marketCap":802935951},{"date":"2021-03-26","current":-119.142665,"twenty":622.879828,"median":723.261143,"eighty":3852.888927,"marketCap":682553292},{"date":"2021-04-01","current":-125.368105,"twenty":614.667992,"median":707.536529,"eighty":3823.227334,"marketCap":715614467},{"date":"2021-04-09","current":-113.562337,"twenty":565.399136,"median":703.755238,"eighty":3814.625044,"marketCap":649492117},{"date":"2021-04-16","current":-112.545567,"twenty":523.879982,"median":686.74313,"eighty":3789.756617,"marketCap":646825893},{"date":"2021-04-23","current":-111.847122,"twenty":514.239421,"median":677.913997,"eighty":3708.005889,"marketCap":645226159},{"date":"2021-04-30","current":-117.931495,"twenty":499.145216,"median":663.056135,"eighty":3573.303695,"marketCap":682553292},{"date":"2021-05-07","current":-104.444617,"twenty":-103.746008,"median":657.010573,"eighty":3560.543427,"marketCap":608432271},{"date":"2021-05-14","current":-87.930916,"twenty":-104.32854,"median":653.509616,"eighty":3549.590569,"marketCap":511914969},{"date":"2021-05-21","current":-93.108401,"twenty":-103.746008,"median":650.811921,"eighty":3495.254806,"marketCap":542309920},{"date":"2021-05-28","current":-81.191712,"twenty":-102.442665,"median":647.009022,"eighty":3431.99515,"marketCap":477787304},{"date":"2021-06-04","current":-87.354472,"twenty":-99.120858,"median":643.585878,"eighty":3412.721906,"marketCap":511914969},{"date":"2021-06-11","current":-121.506119,"twenty":-104.444617,"median":637.621013,"eighty":3382.234713,"marketCap":546042634},{"date":"2021-06-18","current":-123.977073,"twenty":-107.5859,"median":632.756179,"eighty":3113.136829,"marketCap":552441571},{"date":"2021-06-25","current":-117.92327,"twenty":-112.451914,"median":628.277906,"eighty":3015.153489,"marketCap":525246088},{"date":"2021-07-02","current":-123.136182,"twenty":-113.47692,"median":626.857752,"eighty":2293.827654,"marketCap":547109123},{"date":"2021-07-09","current":-125.077341,"twenty":-115.016946,"median":620.420958,"eighty":2293.773606,"marketCap":555107795},{"date":"2021-07-16","current":-121.713107,"twenty":-116.058,"median":613.655707,"eighty":1163.539766,"marketCap":540176941},{"date":"2021-07-23","current":-99.159878,"twenty":-116.704465,"median":606.466795,"eighty":850.313746,"marketCap":439926927},{"date":"2021-07-30","current":-81.962671,"twenty":-116.462081,"median":549.771961,"eighty":839.797655,"marketCap":364739415},{"date":"2021-08-06","current":-95.574708,"twenty":-116.394969,"median":526.361906,"eighty":818.374262,"marketCap":423929584},{"date":"2021-08-13","current":-89.247497,"twenty":-116.058,"median":520.076355,"eighty":806.597318,"marketCap":396200856},{"date":"2021-08-20","current":-79.694483,"twenty":-115.969453,"median":511.361225,"eighty":804.825792,"marketCap":352474786},{"date":"2021-08-27","current":-80.770614,"twenty":-115.609201,"median":502.73304,"eighty":795.69142,"marketCap":358873723},{"date":"2021-09-03","current":-79.12817,"twenty":-115.349844,"median":477.975024,"eighty":791.426272,"marketCap":352474786},{"date":"2021-09-10","current":-80.336523,"twenty":-115.089567,"median":-73.530136,"eighty":787.661523,"marketCap":358473789},{"date":"2021-09-17","current":-67.147557,"twenty":-114.328592,"median":-74.614002,"eighty":784.69718,"marketCap":298617065},{"date":"2021-09-24","current":-58.274486,"twenty":-113.704643,"median":-64.467994,"eighty":777.756776,"marketCap":259156953},{"date":"2021-10-01","current":-49.547641,"twenty":-113.511087,"median":-59.474475,"eighty":764.975361,"marketCap":261823177},{"date":"2021-10-08","current":-49.124934,"twenty":-113.402575,"median":-57.951772,"eighty":755.43077,"marketCap":259690198},{"date":"2021-10-15","current":-50.869488,"twenty":-112.875794,"median":-56.415625,"eighty":744.882323,"marketCap":269288603},{"date":"2021-10-22","current":-50.973165,"twenty":-112.5504,"median":-52.468224,"eighty":738.049419,"marketCap":271954827},{"date":"2021-10-29","current":-50.136495,"twenty":-112.489375,"median":-51.782478,"eighty":736.58443,"marketCap":266622380},{"date":"2021-11-05","current":-44.375169,"twenty":-112.089039,"median":-51.143684,"eighty":735.045674,"marketCap":236227428},{"date":"2021-11-12","current":-45.137305,"twenty":-111.53551,"median":-50.869488,"eighty":733.680259,"marketCap":241026631},{"date":"2021-11-19","current":-50.496354,"twenty":-111.004598,"median":-50.832123,"eighty":732.413224,"marketCap":269288603},{"date":"2021-11-26","current":-43.726266,"twenty":-109.507851,"median":-50.628452,"eighty":731.375604,"marketCap":233027960},{"date":"2021-12-03","current":-37.630589,"twenty":-107.079206,"median":-50.257918,"eighty":724.754232,"marketCap":201033274},{"date":"2021-12-10","current":-34.397058,"twenty":-106.044558,"median":-49.787164,"eighty":712.934839,"marketCap":183969442},{"date":"2021-12-17","current":-26.848373,"twenty":-105.424198,"median":-49.547641,"eighty":707.757935,"marketCap":143442840},{"date":"2021-12-23","current":-12.376015,"twenty":-104.978143,"median":-49.124934,"eighty":706.263236,"marketCap":161039917},{"date":"2021-12-31","current":-11.44257,"twenty":-104.32854,"median":-48.296909,"eighty":705.229584,"marketCap":149308532},{"date":"2022-01-07","current":-12.225705,"twenty":-103.746008,"median":-47.398103,"eighty":701.612256,"marketCap":158906938},{"date":"2022-01-14","current":-11.810924,"twenty":-102.450469,"median":-47.2735,"eighty":692.642017,"marketCap":154107735},{"date":"2022-01-21","current":-10.84717,"twenty":-99.159878,"median":-47.015709,"eighty":691.048767,"marketCap":141843106},{"date":"2022-01-28","current":-10.189171,"twenty":-99.120858,"median":-46.619249,"eighty":682.437492,"marketCap":132777945},{"date":"2022-02-04","current":-10.884816,"twenty":-97.125779,"median":-45.583194,"eighty":680.230928,"marketCap":141843106},{"date":"2022-02-11","current":-11.039292,"twenty":-96.220313,"median":-44.375169,"eighty":677.913997,"marketCap":143976085},{"date":"2022-02-18","current":-8.79016,"twenty":-95.574708,"median":-42.210885,"eighty":667.355176,"marketCap":115180868},{"date":"2022-02-25","current":-8.98141,"twenty":-95.510693,"median":-40.959026,"eighty":667.269098,"marketCap":117847091},{"date":"2022-03-04","current":-8.251982,"twenty":-95.20451,"median":-38.926977,"eighty":660.54127,"marketCap":108248686},{"date":"2022-03-11","current":-7.462995,"twenty":-94.808956,"median":-36.013824,"eighty":658.471288,"marketCap":97583791},{"date":"2022-03-18","current":-8.920915,"twenty":-94.676063,"median":-28.19119,"eighty":657.283046,"marketCap":116247357},{"date":"2022-03-25","current":-18.866826,"twenty":-93.419326,"median":-26.998296,"eighty":656.531581,"marketCap":109819592},{"date":"2022-04-01","current":-19.328292,"twenty":-92.356265,"median":-26.514801,"eighty":654.408413,"marketCap":112551689},{"date":"2022-04-08","current":-21.530715,"twenty":-91.682092,"median":-22.02776,"eighty":653.270851,"marketCap":125355047},{"date":"2022-04-14","current":-24.987257,"twenty":-91.447105,"median":-22.037435,"eighty":652.190207,"marketCap":145176144},{"date":"2022-04-22","current":-27.260737,"twenty":-90.097086,"median":-24.216161,"eighty":651.117511,"marketCap":155354545},{"date":"2022-04-29","current":-28.659399,"twenty":-89.238537,"median":-24.921245,"eighty":650.361632,"marketCap":160680849},{"date":"2022-05-06","current":-27.853548,"twenty":-89.112489,"median":-26.439373,"eighty":648.4806,"marketCap":154808791},{"date":"2022-05-13","current":-27.970843,"twenty":-88.563647,"median":-26.73268,"eighty":646.925485,"marketCap":152673498},{"date":"2022-05-20","current":-23.721773,"twenty":-88.058997,"median":-26.616987,"eighty":646.138503,"marketCap":131320561},{"date":"2022-05-27","current":-23.165322,"twenty":-87.724963,"median":-25.883101,"eighty":643.13573,"marketCap":128117620},{"date":"2022-06-03","current":-26.293113,"twenty":-87.494385,"median":-25.157043,"eighty":640.578044,"marketCap":146267617},{"date":"2022-06-10","current":-25.614648,"twenty":-87.306729,"median":-25.614648,"eighty":638.713845,"marketCap":141463206},{"date":"2022-06-17","current":-23.612227,"twenty":-86.817126,"median":-25.605519,"eighty":636.733849,"marketCap":130252914},{"date":"2022-06-24","current":-27.115854,"twenty":-86.136049,"median":-26.077753,"eighty":635.039908,"marketCap":125982327},{"date":"2022-07-01","current":-28.429368,"twenty":-85.885175,"median":-26.439373,"eighty":633.25475,"marketCap":131854384},{"date":"2022-07-08","current":-30.351577,"twenty":-85.747192,"median":-26.616987,"eighty":631.925226,"marketCap":140929382},{"date":"2022-07-15","current":-29.596306,"twenty":-85.614879,"median":-26.666795,"eighty":629.066628,"marketCap":136124972},{"date":"2022-07-22","current":-27.948235,"twenty":-84.864678,"median":-26.848373,"eighty":628.277906,"marketCap":128651444},{"date":"2022-07-29","current":-27.223763,"twenty":-84.560068,"median":-27.09995,"eighty":627.834765,"marketCap":125448503},{"date":"2022-08-05","current":-26.480595,"twenty":-84.530822,"median":-27.115854,"eighty":627.687586,"marketCap":121711739},{"date":"2022-08-12","current":-23.394954,"twenty":-84.184678,"median":-26.846386,"eighty":626.027918,"marketCap":107832330},{"date":"2022-08-19","current":-23.889037,"twenty":-84.005845,"median":-26.6608,"eighty":620.781101,"marketCap":108899977},{"date":"2022-08-26","current":-25.849463,"twenty":-83.715646,"median":-26.586015,"eighty":620.060815,"marketCap":116907328},{"date":"2022-09-02","current":-23.702662,"twenty":-83.660932,"median":-26.480595,"eighty":618.717133,"marketCap":106764684},{"date":"2022-09-09","current":-23.434761,"twenty":-83.338257,"median":-26.293113,"eighty":614.667992,"marketCap":105163213},{"date":"2022-09-16","current":-23.895191,"twenty":-83.187166,"median":-26.002194,"eighty":612.737131,"marketCap":106230860},{"date":"2022-09-23","current":-64.42075,"twenty":-83.126247,"median":-25.981013,"eighty":610.764129,"marketCap":101188968},{"date":"2022-09-30","current":-74.451171,"twenty":-82.37477,"median":-26.212622,"eighty":604.149898,"marketCap":117166174},{"date":"2022-10-07","current":-65.317656,"twenty":-82.044955,"median":-26.480595,"eighty":565.399136,"marketCap":102786689},{"date":"2022-10-14","current":-65.33401,"twenty":-81.971895,"median":-26.586015,"eighty":551.037088,"marketCap":101721542},{"date":"2022-10-21","current":-65.094013,"twenty":-81.820527,"median":-26.6608,"eighty":536.538185,"marketCap":100656395},{"date":"2022-10-28","current":-56.233875,"twenty":-81.757557,"median":-26.846386,"eighty":531.044705,"marketCap":86809483},{"date":"2022-11-04","current":-68.679106,"twenty":-81.439956,"median":-27.115854,"eighty":523.879982,"marketCap":107047277},{"date":"2022-11-11","current":-57.472225,"twenty":-81.334594,"median":-27.190076,"eighty":521.320286,"marketCap":90537498},{"date":"2022-11-18","current":-73.830342,"twenty":-81.266321,"median":-27.322252,"eighty":520.279887,"marketCap":116101027},{"date":"2022-11-25","current":-69.24178,"twenty":-81.21542,"median":-27.372342,"eighty":518.547538,"marketCap":108112424},{"date":"2022-12-02","current":-70.787846,"twenty":-81.038495,"median":-27.470153,"eighty":515.061647,"marketCap":112905586},{"date":"2022-12-09","current":11.251796,"twenty":-80.836909,"median":-27.518685,"eighty":510.950031,"marketCap":107524840},{"date":"2022-12-16","current":12.895086,"twenty":-80.510159,"median":-27.382731,"eighty":506.132555,"marketCap":122961574},{"date":"2022-12-23","current":13.931198,"twenty":-80.01649,"median":-27.322252,"eighty":503.246793,"marketCap":132542996},{"date":"2022-12-30","current":14.359267,"twenty":-79.759674,"median":-27.223763,"eighty":500.939128,"marketCap":138398309},{"date":"2023-01-06","current":21.077172,"twenty":-79.597373,"median":-27.148219,"eighty":494.557622,"marketCap":204935958},{"date":"2023-01-13","current":20.255524,"twenty":-79.192781,"median":-26.966209,"eighty":479.067051,"marketCap":200677548},{"date":"2023-01-20","current":20.474685,"twenty":-79.12817,"median":-26.758595,"eighty":476.154977,"marketCap":200677548},{"date":"2023-01-27","current":20.531717,"twenty":-77.967048,"median":-26.619311,"eighty":21.589051,"marketCap":201209849},{"date":"2023-02-03","current":15.648931,"twenty":-77.398452,"median":-26.534921,"eighty":21.077172,"marketCap":153835043},{"date":"2023-02-10","current":14.716537,"twenty":-76.140032,"median":-26.439373,"eighty":20.611136,"marketCap":143721321},{"date":"2023-02-17","current":15.672184,"twenty":-75.039113,"median":-26.077753,"eighty":20.531717,"marketCap":151705839},{"date":"2023-02-24","current":17.712209,"twenty":-74.699024,"median":-25.970433,"eighty":20.486091,"marketCap":169271778},{"date":"2023-03-03","current":20.018891,"twenty":-74.560532,"median":-25.736073,"eighty":20.419914,"marketCap":192693030},{"date":"2023-03-10","current":18.127093,"twenty":-74.47037,"median":-25.472181,"eighty":20.285663,"marketCap":174062489},{"date":"2023-03-17","current":16.872549,"twenty":-73.954508,"median":-25.301422,"eighty":20.253874,"marketCap":162884164},{"date":"2023-03-24","current":16.222086,"twenty":-72.382996,"median":-24.886301,"eighty":20.065805,"marketCap":157028851},{"date":"2023-03-31","current":10.787756,"twenty":-71.3665,"median":-24.752338,"eighty":20.013517,"marketCap":172465585},{"date":"2023-04-06","current":10.614379,"twenty":-71.119552,"median":-24.651893,"eighty":20.01091,"marketCap":169530932},{"date":"2023-04-14","current":10.897737,"twenty":-70.89832,"median":-24.529866,"eighty":19.995566,"marketCap":174228905},{"date":"2023-04-21","current":10.642547,"twenty":-70.662676,"median":-24.344147,"eighty":19.981604,"marketCap":170062377},{"date":"2023-04-28","current":10.261973,"twenty":-70.26897,"median":-24.087287,"eighty":19.726204,"marketCap":162759014},{"date":"2023-05-05","current":10.375731,"twenty":-69.896663,"median":-23.989384,"eighty":19.345672,"marketCap":164872768},{"date":"2023-05-12","current":10.699055,"twenty":-69.754458,"median":-23.895191,"eighty":19.258934,"marketCap":169100275},{"date":"2023-05-19","current":12.738201,"twenty":-69.647672,"median":-23.817492,"eighty":19.138658,"marketCap":198692823},{"date":"2023-05-26","current":10.145318,"twenty":-69.486863,"median":-23.706814,"eighty":19.049996,"marketCap":157474631},{"date":"2023-06-02","current":8.912544,"twenty":-69.309827,"median":-23.66934,"eighty":18.925288,"marketCap":137922411},{"date":"2023-06-09","current":9.478231,"twenty":-69.195614,"median":-23.578708,"eighty":18.8846,"marketCap":146377425},{"date":"2023-06-16","current":9.95334,"twenty":-68.977174,"median":-23.434761,"eighty":18.784254,"marketCap":153247124},{"date":"2023-06-23","current":7.317993,"twenty":-68.842076,"median":-23.332567,"eighty":18.682471,"marketCap":153247124},{"date":"2023-06-30","current":7.621083,"twenty":-68.7117,"median":-23.313042,"eighty":18.595573,"marketCap":158003069},{"date":"2023-07-07","current":7.569581,"twenty":-68.57814,"median":-23.165322,"eighty":18.516354,"marketCap":156946192},{"date":"2023-07-14","current":7.74125,"twenty":-68.360527,"median":-23.084847,"eighty":18.357204,"marketCap":162759014},{"date":"2023-07-21","current":7.415726,"twenty":-68.154458,"median":-22.784028,"eighty":18.262726,"marketCap":155360877},{"date":"2023-07-28","current":7.58943,"twenty":-67.928832,"median":-22.552521,"eighty":18.177631,"marketCap":159059946},{"date":"2023-08-04","current":8.538508,"twenty":-67.786772,"median":-22.067165,"eighty":18.036212,"marketCap":179140604},{"date":"2023-08-11","current":8.599752,"twenty":-67.392925,"median":-21.761057,"eighty":17.926251,"marketCap":179140604},{"date":"2023-08-18","current":8.200541,"twenty":-67.098258,"median":-21.082907,"eighty":17.784659,"marketCap":169100275},{"date":"2023-08-25","current":7.609195,"twenty":-67.057337,"median":-19.928268,"eighty":17.708857,"marketCap":157210412},{"date":"2023-09-01","current":7.245142,"twenty":-67.046398,"median":-19.328292,"eighty":17.625182,"marketCap":150076494},{"date":"2023-09-08","current":8.165334,"twenty":-66.784088,"median":-18.866826,"eighty":17.482007,"marketCap":167514960},{"date":"2023-09-15","current":7.87776,"twenty":-66.329394,"median":-12.52392,"eighty":17.258673,"marketCap":162759014},{"date":"2023-09-22","current":6.744063,"twenty":-66.219838,"median":-12.376015,"eighty":17.023211,"marketCap":157474631},{"date":"2023-09-29","current":6.570956,"twenty":-66.144779,"median":-12.298084,"eighty":16.797331,"marketCap":153565006},{"date":"2023-10-06","current":6.632418,"twenty":-65.908841,"median":-12.175509,"eighty":16.676727,"marketCap":155005668},{"date":"2023-10-12","current":6.434946,"twenty":-65.651474,"median":-11.881642,"eighty":16.655339,"marketCap":150398718},{"date":"2023-10-20","current":5.972544,"twenty":-65.488282,"median":-11.523642,"eighty":16.591901,"marketCap":139316707},{"date":"2023-10-27","current":5.860553,"twenty":-65.487919,"median":-11.464021,"eighty":16.54281,"marketCap":136678133},{"date":"2023-11-03","current":5.860233,"twenty":-65.478141,"median":-11.354541,"eighty":16.489434,"marketCap":136678133},{"date":"2023-11-10","current":5.965953,"twenty":-65.389152,"median":-11.135132,"eighty":16.41522,"marketCap":139770541},{"date":"2023-11-17","current":6.046997,"twenty":-65.324198,"median":-11.039292,"eighty":16.308917,"marketCap":142482996},{"date":"2023-11-24","current":5.635263,"twenty":-65.228199,"median":-10.915602,"eighty":16.260424,"marketCap":134567274},{"date":"2023-12-01","current":6.069161,"twenty":-64.910178,"median":-10.865993,"eighty":16.236684,"marketCap":145121570},{"date":"2023-12-08","current":5.778828,"twenty":-64.593491,"median":-10.516533,"eighty":16.211144,"marketCap":137997420},{"date":"2023-12-15","current":6.061528,"twenty":-64.487554,"median":-10.314987,"eighty":16.18531,"marketCap":145649284},{"date":"2023-12-22","current":6.073073,"twenty":-64.323712,"median":-10.189171,"eighty":16.139946,"marketCap":145121570},{"date":"2023-12-29","current":5.949859,"twenty":-64.178155,"median":-10.088679,"eighty":16.093099,"marketCap":153301149},{"date":"2024-01-05","current":5.805284,"twenty":-64.099823,"median":-9.94021,"eighty":16.022939,"marketCap":148726216},{"date":"2024-01-12","current":5.514377,"twenty":-63.618717,"median":-9.468635,"eighty":15.900232,"marketCap":141342645},{"date":"2024-01-19","current":6.115656,"twenty":-63.325946,"median":-9.196155,"eighty":15.818308,"marketCap":155582389},{"date":"2024-01-26","current":5.636805,"twenty":-63.196265,"median":-9.088655,"eighty":15.752752,"marketCap":144507032},{"date":"2024-02-02","current":4.964524,"twenty":-62.945888,"median":-8.877979,"eighty":15.703782,"marketCap":126575503},{"date":"2024-02-09","current":4.721345,"twenty":-62.418765,"median":-8.79016,"eighty":15.666016,"marketCap":120774125},{"date":"2024-02-16","current":4.852088,"twenty":-61.561414,"median":-8.645478,"eighty":15.653631,"marketCap":123938513},{"date":"2024-02-23","current":4.714409,"twenty":-61.165479,"median":-8.394602,"eighty":15.648455,"marketCap":119983029},{"date":"2024-03-01","current":4.204659,"twenty":-60.897027,"median":-8.293682,"eighty":15.644092,"marketCap":107061779},{"date":"2024-03-08","current":4.0195,"twenty":-60.462721,"median":-7.902436,"eighty":15.623894,"marketCap":101099140},{"date":"2024-03-15","current":4.08959,"twenty":-59.288225,"median":-7.109283,"eighty":15.559961,"marketCap":102844866},{"date":"2024-03-22","current":3.756903,"twenty":-58.489478,"median":-0.597309,"eighty":15.461807,"marketCap":94406313},{"date":"2024-03-28","current":3.581788,"twenty":-58.274486,"median":3.785359,"eighty":15.429213,"marketCap":89659626},{"date":"2024-04-05","current":3.754028,"twenty":-58.103317,"median":3.754028,"eighty":15.265664,"marketCap":93878903},{"date":"2024-04-12","current":3.93018,"twenty":-57.800228,"median":3.753613,"eighty":15.153111,"marketCap":98240580},{"date":"2024-04-19","current":3.619091,"twenty":-57.472225,"median":3.754028,"eighty":14.825454,"marketCap":90450741},{"date":"2024-04-26","current":3.696217,"twenty":-56.803966,"median":3.745618,"eighty":14.749615,"marketCap":92296674},{"date":"2024-05-03","current":3.672048,"twenty":-56.415625,"median":3.710255,"eighty":14.716537,"marketCap":91769265},{"date":"2024-05-10","current":3.572862,"twenty":-56.233875,"median":3.704611,"eighty":14.545739,"marketCap":89516801},{"date":"2024-05-17","current":3.992595,"twenty":-54.288637,"median":3.72302,"eighty":14.504524,"marketCap":100048189},{"date":"2024-05-24","current":4.215887,"twenty":-53.28149,"median":3.745854,"eighty":14.359267,"marketCap":105313884},{"date":"2024-05-31","current":4.173666,"twenty":-53.217826,"median":3.753613,"eighty":14.206804,"marketCap":104260745},{"date":"2024-06-07","current":4.228116,"twenty":-52.954726,"median":3.756363,"eighty":13.978696,"marketCap":105577168},{"date":"2024-06-14","current":4.263687,"twenty":-52.66213,"median":3.77762,"eighty":13.734399,"marketCap":106367022},{"date":"2024-06-21","current":3.909764,"twenty":-52.476232,"median":3.813814,"eighty":13.427207,"marketCap":97415342},{"date":"2024-06-28","current":3.956328,"twenty":-52.444201,"median":3.815294,"eighty":13.251214,"marketCap":98468481},{"date":"2024-07-05","current":4.428231,"twenty":-52.374063,"median":3.843672,"eighty":13.075932,"marketCap":91096509},{"date":"2024-07-12","current":4.292969,"twenty":-52.159314,"median":3.862231,"eighty":12.944148,"marketCap":88463662},{"date":"2024-07-15","current":4.188792,"twenty":-52.099759,"median":3.872037,"eighty":12.919617,"marketCap":86357384},{"date":"2024-08-02","current":4.079809,"twenty":-52.040203,"median":3.876302,"eighty":12.895086,"marketCap":84251107},{"date":"2024-08-09","current":4.016242,"twenty":-51.782478,"median":3.880567,"eighty":12.738201,"marketCap":83724537},{"date":"2024-08-16","current":3.990932,"twenty":-51.641514,"median":3.892399,"eighty":12.704329,"marketCap":83197968},{"date":"2024-08-23","current":4.075087,"twenty":-51.157034,"median":3.894801,"eighty":12.522599,"marketCap":85304246},{"date":"2024-08-30","current":3.898504,"twenty":-51.130333,"median":3.903824,"eighty":12.321334,"marketCap":82144829},{"date":"2024-09-06","current":3.870408,"twenty":-51.121558,"median":3.906794,"eighty":11.93542,"marketCap":81618260},{"date":"2024-09-13","current":3.859099,"twenty":-51.002405,"median":3.903824,"eighty":11.456534,"marketCap":81091690},{"date":"2024-09-20","current":3.9671,"twenty":-50.890223,"median":3.9082,"eighty":11.273623,"marketCap":83950962},{"date":"2024-09-27","current":4.319659,"twenty":-50.809704,"median":3.909764,"eighty":11.108562,"marketCap":92149648},{"date":"2024-10-04","current":5.879801,"twenty":-50.767392,"median":3.931399,"eighty":11.029879,"marketCap":110501873},{"date":"2024-10-11","current":5.499863,"twenty":-50.549193,"median":3.939908,"eighty":10.979463,"marketCap":102646289},{"date":"2024-10-18","current":5.214344,"twenty":-50.442871,"median":3.958702,"eighty":10.954849,"marketCap":96754602},{"date":"2024-10-25","current":5.219422,"twenty":-50.292234,"median":3.966788,"eighty":10.944012,"marketCap":96885528},{"date":"2024-10-31","current":5.105491,"twenty":-50.185064,"median":3.968042,"eighty":10.942007,"marketCap":94790706},{"date":"2024-11-08","current":5.167096,"twenty":-50.081411,"median":3.991764,"eighty":10.930004,"marketCap":95529131},{"date":"2024-11-15","current":4.672759,"twenty":-49.897475,"median":4.008147,"eighty":10.907481,"marketCap":85364006},{"date":"2024-11-22","current":4.440508,"twenty":-49.78473,"median":4.0271,"eighty":10.878829,"marketCap":81069620},{"date":"2024-11-29","current":4.736699,"twenty":-49.6958,"median":4.040143,"eighty":10.857926,"marketCap":86411417},{"date":"2024-12-06","current":4.689102,"twenty":-49.565261,"median":4.04993,"eighty":10.843894,"marketCap":85364006},{"date":"2024-12-13","current":4.838269,"twenty":-49.5214,"median":4.067482,"eighty":10.830193,"marketCap":87982534},{"date":"2024-12-20","current":5.089027,"twenty":-49.339197,"median":4.079809,"eighty":10.809498,"marketCap":92172178},{"date":"2024-12-27","current":6.383451,"twenty":-49.076179,"median":4.096351,"eighty":10.803058,"marketCap":92172178},{"date":"2025-01-03","current":6.149372,"twenty":-48.881161,"median":4.109295,"eighty":10.799568,"marketCap":88776402},{"date":"2025-01-10","current":6.013414,"twenty":-48.785915,"median":4.112845,"eighty":10.790662,"marketCap":86426438},{"date":"2025-01-17","current":6.249589,"twenty":-48.017792,"median":4.116582,"eighty":10.787892,"marketCap":89820830},{"date":"2025-01-24","current":5.959023,"twenty":-47.641921,"median":4.161776,"eighty":10.760214,"marketCap":86165331},{"date":"2025-01-31","current":6.018765,"twenty":-47.445019,"median":4.173666,"eighty":10.730465,"marketCap":87470866},{"date":"2025-02-07","current":6.284576,"twenty":-47.356742,"median":4.176545,"eighty":10.708582,"marketCap":90865258},{"date":"2025-02-14","current":6.707059,"twenty":-47.326502,"median":4.204659,"eighty":10.66515,"marketCap":96912498},{"date":"2025-02-21","current":6.723628,"twenty":-47.283745,"median":4.218352,"eighty":10.63128,"marketCap":97654042},{"date":"2025-02-28","current":7.467655,"twenty":-47.216733,"median":4.228962,"eighty":10.608026,"marketCap":108098324},{"date":"2025-03-07","current":7.685188,"twenty":-47.054251,"median":4.238658,"eighty":10.595139,"marketCap":111753823},{"date":"2025-03-14","current":9.29828,"twenty":-46.801402,"median":4.25916,"eighty":10.589398,"marketCap":135253459},{"date":"2025-03-21","current":9.805225,"twenty":-46.709104,"median":4.263687,"eighty":10.608026,"marketCap":142564457},{"date":"2025-03-28","current":9.162264,"twenty":-46.618583,"median":4.29309,"eighty":10.595139,"marketCap":124320249},{"date":"2025-04-04","current":8.29809,"twenty":-46.382185,"median":4.29859,"eighty":10.589398,"marketCap":112356376}],"updateTime":1743966188368}}}